Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Cell ProTx

Cell ProTx

Innovation in therapeutic approaches to protect human cells and tissue from damage


Presenter:

Donald McPhail, COO

CHAIN Biotech

CHAIN Biotech

Developing new Clostridium-based microbial technology for high value healthcare products


Presenter:

Edward Green, CEO

ChemoGel

ChemoGel

Developing a thermoresponsive gel drug delivery platform for local and site specific treatment of solid tumours


Presenter:

Derek John, Technology Transfer Case Manager

Cotton Mouton Diagnostics

Cotton Mouton Diagnostics

Developed a rapid and novel point-of-need analytical platform based on proprietary intellectual property


Presenter:

James Thurlow, CEO

Enpathy Therapeutics

Enpathy Therapeutics

Early stage drug discovery company, developing new small molecules therapies for liver and cardiometabolic diseases


Presenter:

Gareth Blades, University of Edinburgh

Epinostix

Epinostix

Epinostix Ltd, aims to improve early diagnosis of cancer


Presenter:

John Kelly, Founder, Epinostix

Exputec

Exputec

Technology-driven consulting and software company delivering solutions for the biotech and chemical process industry


Presenter:

Ulrich Troeller, Managing Director

FitnessGenes Ltd

FitnessGenes Ltd

World leader for interpreting DNA, genetic traits, and environmental data


Presenter:

Samantha Debombel, CSO

Inflection Biosciences

Inflection Biosciences

Developing small molecule therapeutics for the treatment of cancer


Presenter:

Michael O'Neill, Director of R&D

InnovoSep

InnovoSep

Developing new therapies for sepsis based on Cilengitide, a potent inhibitor of αVβ3 integrin signalling


Presenter:

Derek John, Technology Transfer Case Manager

Invisio

Invisio

Improving the therapy experience of patients, resulting in better overall outcomes


Presenter:

Russ Pendleton, CEO

Invizius

Invizius

Improving treatment for dialysis patients


Presenter:

Richard Boyd, CEO